MC4R | Melanocortin 4 receptor | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
MC5R | Melanocortin 5 receptor | G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
MRGPRD | MAS-related GPR, member D | G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
MRGPRE | MAS-related GPR, member E | G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
MRGPRF | MAS-related GPR, member F | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
MRGPRG | MAS-related GPR, member G | G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
MRGPRX2 | MAS-related GPR, member X2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
NMBR | Neuromedin B receptor | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
NMUR1 | Neuromedin U receptor 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
NMUR2 | Neuromedin U receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
NPFFR1 | Neuropeptide FF receptor 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
NPFFR2 | Neuropeptide FF receptor 2 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NPSR1 | Neuropeptide S receptor 1 | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
NPY1R | Neuropeptide Y receptor Y1 | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
NPY4R | Neuropeptide Y receptor Y4 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
NPY5R | Neuropeptide Y receptor Y5 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
NTSR1 | Neurotensin receptor 1 (high affinity) | G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
OPN3 | Opsin 3 | G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
OPN4 | Opsin 4 | G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
OPRD1 | Opioid receptor, delta 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
OPRK1 | Opioid receptor, kappa 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
OPRM1 | Opioid receptor, mu 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
OXER1 | Oxoeicosanoid (OXE) receptor 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
OXTR | Oxytocin receptor | FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
P2RY1 | Purinergic receptor P2Y, G-protein coupled, 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
P2RY10 | Purinergic receptor P2Y, G-protein coupled, 10 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
P2RY11 | Purinergic receptor P2Y, G-protein coupled, 11 | G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
P2RY12 | Purinergic receptor P2Y, G-protein coupled, 12 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
P2RY13 | Purinergic receptor P2Y, G-protein coupled, 13 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
P2RY14 | Purinergic receptor P2Y, G-protein coupled, 14 | G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
P2RY2 | Purinergic receptor P2Y, G-protein coupled, 2 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
P2RY4 | Pyrimidinergic receptor P2Y, G-protein coupled, 4 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
P2RY6 | Pyrimidinergic receptor P2Y, G-protein coupled, 6 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
P2RY8 | Purinergic receptor P2Y, G-protein coupled, 8 | Cancer-related genes G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
PRLHR | Prolactin releasing hormone receptor | G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
PROKR1 | Prokineticin receptor 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
PROKR2 | Prokineticin receptor 2 | Disease related genes G-protein coupled receptors Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
PTAFR | Platelet-activating factor receptor | G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Mixed |
PTGDR2 | Prostaglandin D2 receptor 2 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
PTGER3 | Prostaglandin E receptor 3 (subtype EP3) | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
PTGER4 | Prostaglandin E receptor 4 (subtype EP4) | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Expressed in all |
PTH1R | Parathyroid hormone 1 receptor | Disease related genes G-protein coupled receptors Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
PTH2R | Parathyroid hormone 2 receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
QRFPR | Pyroglutamylated RFamide peptide receptor | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
RRH | Retinal pigment epithelium-derived rhodopsin homolog | G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
RXFP1 | Relaxin/insulin-like family peptide receptor 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
RXFP3 | Relaxin/insulin-like family peptide receptor 3 | G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
S1PR1 | Sphingosine-1-phosphate receptor 1 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Expressed in all |
S1PR2 | Sphingosine-1-phosphate receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
S1PR3 | Sphingosine-1-phosphate receptor 3 | G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |